The In Vivo Coating of Tumor Cells by Potentially Cytotoxic Antitumor Antibodies

  • Maya Ran
  • Isaac P. Witz
  • George Kleint


Masking of cell surface antigens was first suggested as one of the mechanisms by which enhancing antibodies operate in a tumor bearing host (1). Such a masking, inferred also from studies showing that in vivo growing tumor cells are coated with immunoglobulin (Ig), is lately considered a key event in many alternative pathways by which the tumor escapes the immune reactivity of the host (2). This consideration is supported by the following indirect evidence: 1. Enhancement of tumor growth by immunoglobulin (Ig)-containing tumor eluates (3–4). 2. Blocking of in vitro cell mediated antitumor activity by tumor eluates, of human and animal origin (4–6). 3. Demonstration of an increased ability of human tumor cells to stimulate DNA synthesis in autochthonous lymphocytes following “unmasking” of tumor antigens (7). The association between tumor cell surface and Ig has been demonstrated directly (8). Yet it is not clear whether the coating of tumor cells by Ig and the masking of cell surface antigens is the very same phenomenon. This study was aimed to determine whether part of the Ig coating of Polyoma virus induced mouse tumor cells (SEYF-a, 9) consists of specific antibodies.


Antigenic Determinant Cell Surface Antigen Rabbit Anti Mouse Antibody Cytotoxic Antibody Unlabelled Competitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Moller, G. Nature, 204: 846, 1964.PubMedCrossRefGoogle Scholar
  2. Witz, I.P., Levy, H.S., Keisari, Y. and Izsak, F. Ch. In: “The Role of Immunoligical Factors in Viral and Oncogenic Processes” (Bears, R.S. Jr., Tilghman, R.C., Bassett, E.G. eds.) Baltimore, Maryland, John Hopkins University Press. 289, 1974.Google Scholar
  3. Bansal, S.C., Hargreaves, R. and Sjogren, H.O. Int. J. Cancer, 9: 97, 1972.Google Scholar
  4. Ran, M. and Witz, I.P. Int. J. Cancer, 9: 242, 1972.PubMedCrossRefGoogle Scholar
  5. Sjogren, H.O., Hellstrom, I., Bansal, S.E. Warner, G.A. and Hellstrom, E.K. Int. J. Cancer 9: 274, 1972.PubMedCrossRefGoogle Scholar
  6. Sjogren, H.O. and Bansal, S.C. Prog. Immunol., 1: 921, 1971.Google Scholar
  7. Stjernsward, J. and Vanky, F. Natl. Cancer Inst. Monogr. 35: 237, 1972.PubMedGoogle Scholar
  8. Witz, I.P. Current Topics in Microbiol. & Immunol. 61: 151, 1973Google Scholar
  9. Sjogren, H.O. J. Nat. Cancer Inst. 32: 361, 1964.Google Scholar
  10. Ran, M., Fish, F., Witz, I.P. and Klein, G. Clin. Exp. Immunol. 16: 335, 1974Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Maya Ran
    • 1
  • Isaac P. Witz
    • 1
  • George Kleint
    • 2
  1. 1.Department of Microbiology, The George S. Wise Center for Life SciencesTel Aviv UniversityTel AvivIsrael
  2. 2.Department of Tumor BiologyKarolinska InstitutetStockholmSweden

Personalised recommendations